))
Highlights from 2024 World Conference on Lung Cancer
Manage episode 443194987 series 3560283
Content provided by Healio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting.
Benjamin P. Levy, MD, discusses key takeaways from the meeting. 0:28
Read the full coverage here:
Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’
Source: Zhou C, et al. Abstract 2700. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego.
Perioperative nivolumab improves outcomes in resectable NSCLC
Source: Forde PM, et al. Abstract 3589. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego.
Despite progress, barriers to lung cancer biomarker testing persist
Source: Smeltzer M, et al. Abstract 3000. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego.
Disclosures: Healio could not confirm relevant financial disclosures for Levy at the time of posting.
13 episodes
Share
